Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Ameliorative Effects of Acanthopanax trifoliatus on Cognitive and Emotional Deficits in Olfactory Bulbectomized Mice: An Animal Model of Depression and Cognitive Deficits.

Sithisarn P, Rojsanga P, Jarikasem S, Tanaka K, Matsumoto K.

Evid Based Complement Alternat Med. 2013;2013:701956. doi: 10.1155/2013/701956. Epub 2013 Mar 21.

2.

Butea superba-induced amelioration of cognitive and emotional deficits in olfactory bulbectomized mice and putative mechanisms underlying its actions.

Mizuki D, Qi Z, Tanaka K, Fujiwara H, Ishikawa T, Higuchi Y, Matsumoto K.

J Pharmacol Sci. 2014;124(4):457-67. Epub 2014 Mar 19.

3.

Thunbergia laurifolia extract ameliorates cognitive and emotional deficits in olfactorectomized mice.

Rojsanga P, Sithisarn P, Tanaka K, Mizuki D, Matsumoto K.

Pharm Biol. 2015 Aug;53(8):1141-8. doi: 10.3109/13880209.2014.962059. Epub 2015 Jan 22.

PMID:
25609149
4.

Bacopa monnieri ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems.

Le XT, Pham HT, Do PT, Fujiwara H, Tanaka K, Li F, Van Nguyen T, Nguyen KM, Matsumoto K.

Neurochem Res. 2013 Oct;38(10):2201-15. doi: 10.1007/s11064-013-1129-6. Epub 2013 Aug 15.

PMID:
23949198
5.

Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.

Yamada M, Hayashida M, Zhao Q, Shibahara N, Tanaka K, Miyata T, Matsumoto K.

J Ethnopharmacol. 2011 Jun 1;135(3):737-46. doi: 10.1016/j.jep.2011.04.010. Epub 2011 Apr 12.

PMID:
21513784
6.

Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice.

Moriguchi S, Tanaka T, Tagashira H, Narahashi T, Fukunaga K.

Behav Brain Res. 2013 Apr 1;242:150-7. doi: 10.1016/j.bbr.2012.12.054. Epub 2013 Jan 4.

PMID:
23295391
7.

Chotosan, a kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice.

Zhao Q, Murakami Y, Tohda M, Obi R, Shimada Y, Matsumoto K.

J Pharmacol Sci. 2007 Apr;103(4):360-73. Epub 2007 Mar 31.

8.

Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats.

Kalshetti PB, Alluri R, Mohan V, Thakurdesai PA.

Pharmacogn Mag. 2015 Oct;11(Suppl 3):S388-96. doi: 10.4103/0973-1296.168980.

9.

Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.

Zhao Q, Niu Y, Matsumoto K, Tsuneyama K, Tanaka K, Miyata T, Yokozawa T.

BMC Complement Altern Med. 2012 Oct 20;12:188. doi: 10.1186/1472-6882-12-188.

10.

Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.

Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B.

Biol Psychiatry. 2007 Apr 15;61(8):990-5. Epub 2006 Dec 4.

PMID:
17141743
11.

Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.

Hendriksen H, Meulendijks D, Douma TN, Bink DI, Breuer ME, Westphal KG, Olivier B, Oosting RS.

Neuropharmacology. 2012 Jan;62(1):270-7. doi: 10.1016/j.neuropharm.2011.07.018. Epub 2011 Jul 22.

PMID:
21807004
12.

Behavior and the cholinergic parameters in olfactory bulbectomized female rodents: Difference between rats and mice.

Stepanichev M, Markov D, Pasikova N, Gulyaeva N.

Behav Brain Res. 2016 Jan 15;297:5-14. doi: 10.1016/j.bbr.2015.09.033. Epub 2015 Sep 30.

PMID:
26431763
13.

The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice.

Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K.

Neuroscience. 2008 Feb 6;151(3):671-9. doi: 10.1016/j.neuroscience.2007.11.011. Epub 2007 Nov 17.

PMID:
18164824
14.

Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.

Saitoh A, Yamada M, Yamada M, Takahashi K, Yamaguchi K, Murasawa H, Nakatani A, Tatsumi Y, Hirose N, Kamei J.

Brain Res. 2008 May 7;1208:160-9. doi: 10.1016/j.brainres.2007.07.095. Epub 2007 Sep 4.

PMID:
18381208
15.

BE360, a new selective estrogen receptor modulator, produces antidepressant and antidementia effects through the enhancement of hippocampal cell proliferation in olfactory bulbectomized mice.

Nakagawasai O, Nemoto W, Onogi H, Moriya T, Lin JR, Odaira T, Yaoita F, Ogawa T, Ohta K, Endo Y, Tan-No K.

Behav Brain Res. 2016 Jan 15;297:315-22. doi: 10.1016/j.bbr.2015.10.033. Epub 2015 Oct 20.

PMID:
26497104
16.

Antidepressant-like effect of Butea superba in mice exposed to chronic mild stress and its possible mechanism of action.

Mizuki D, Matsumoto K, Tanaka K, Thi Le X, Fujiwara H, Ishikawa T, Higuchi Y.

J Ethnopharmacol. 2014 Oct 28;156:16-25. doi: 10.1016/j.jep.2014.08.014. Epub 2014 Aug 23.

PMID:
25152298
17.

Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.

Takahashi K, Nakagawasai O, Nemoto W, Nakajima T, Arai Y, Hisamitsu T, Tan-No K.

Psychopharmacology (Berl). 2016 Apr;233(7):1311-22. doi: 10.1007/s00213-016-4224-y. Epub 2016 Feb 9.

PMID:
26856855
18.

Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration.

Borre Y, Bosman E, Lemstra S, Westphal KG, Olivier B, Oosting RS.

Neuropharmacology. 2012 Apr;62(5-6):2010-7. doi: 10.1016/j.neuropharm.2011.12.034. Epub 2012 Jan 11.

PMID:
22248638
19.

SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

Breuer ME, van Gaalen MM, Wernet W, Claessens SE, Oosting RS, Behl B, Korte SM, Schoemaker H, Gross G, Olivier B, Groenink L.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):101-6. doi: 10.1007/s00210-008-0336-1. Epub 2008 Jul 31.

PMID:
18668225
20.

[Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior].

Shioda N, Yamamoto Y, Han F, Moriguchi S, Fukunaga K.

Yakugaku Zasshi. 2011 Apr;131(4):505-11. Review. Japanese.

Supplemental Content

Support Center